3IK3

AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance

ENTITY

7QH8_1

Lysine--tRNA ligase 1 - Mycobacterium tuberculosis H37Rv

CHROMOSOME

P9WFU9

P9WFU9 5'

3'

7QH8_1

LOADING 67%

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.